Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

By D. Planas, Nell Saunders, Piet Maes, F. Guivel-Benhassine, C. Planchais, Julian Buchrieser, William Bolland, F. Porrot, I. Staropoli, F. Lemoine and 22 more. Nature, 2021

1,416 citations recorded by the source corpus.

Subfields: Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/cf9d5b0c4a319a344661ae65cdd59650a407c3e7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. C. Cohen
2. Jonathan Dushoff
3. N. Govender
4. J. Pulliam
5. H. Moultrie
6. M. Groome
7. C. van Schalkwyk

Citations in the corpus

• Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa (2022, positive): “Laboratory-based studies suggest that convalescent serum has a reduced neutralizing effect on the Beta, Delta, and Omicron variants compared to wild type virus in vitro ( 7 – 12 ); however, this finding does not necessarily translate into immune evasion at the population level.”
• Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants (2022, neutral): “1 were greatly or completely resistant to all RBD class 1 and class 3 mAbs tested as well as to one RBD class 2 mAb (XGv051), a class 4 mAb (10-40), and an NTD-SD2 mAb (C1717).”